Equity Overview
Price & Market Data
Price: $2.15
Daily Change: -$0.08 / 3.72%
Range: $2.15 - $2.16
Market Cap: $91,096,616
Volume: 1,558
Performance Metrics
1 Week: -2.19%
1 Month: -0.45%
3 Months: -9.72%
6 Months: -7.08%
1 Year: 6.19%
YTD: -7.85%
Company Details
Employees: 13
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.